Stock prices have plunged sharply in early trade and sent the benchmark BSE index Sensex crashing down by 230.95 points or nearly 1.5% to 15,193.83 now. The Nifty has tumbled 1.27% or 58 points to 4524.40.
Stocks across the board have taken a beating in a massive sell-off that has erupted due to weak global sentiment. The mood is so bearish that only Hindalco (up nearly a per cent) among the Sensex components has made it to the positive territory at present.
Maruti Suzuki, down 3.2% at Rs 740.50, is among the most prominent losers in the Sensex. BHEL, DLF, Grasim Industries, Hindustan Unilever, HDFC, HDFC Bank, ICICI Bank, Infosys Technologies, Jaiprakash Associates, NTPC, ONGC, Reliance Industries, Satyam Computer Services, State Bank of India, Tata Motors, Tata Consultancy Services and Wipro have declined sharply.
Ranbaxy Laboratories has settled all pending patent disputes it has world over with Pfizer Inc. This include the high profile patent litigations involving Atorvastatin (Lipitor), the world's most-prescribed cholesterol-lowering medicine with worldwide sales of $12.7 billion world wide. The Ranbaxy stock is down in the red with a sharp loss of 3.65.
Unitech, Power Grid, Siemens, PNB, BPCL, Tata Power, ABB, Hero Honda, Reliance Petroleum, Tata Communications, HCL Technologies and Idea Cellular are among the major losers in the Nifty index.
Stocks across the board have taken a beating in a massive sell-off that has erupted due to weak global sentiment. The mood is so bearish that only Hindalco (up nearly a per cent) among the Sensex components has made it to the positive territory at present.
Maruti Suzuki, down 3.2% at Rs 740.50, is among the most prominent losers in the Sensex. BHEL, DLF, Grasim Industries, Hindustan Unilever, HDFC, HDFC Bank, ICICI Bank, Infosys Technologies, Jaiprakash Associates, NTPC, ONGC, Reliance Industries, Satyam Computer Services, State Bank of India, Tata Motors, Tata Consultancy Services and Wipro have declined sharply.
Ranbaxy Laboratories has settled all pending patent disputes it has world over with Pfizer Inc. This include the high profile patent litigations involving Atorvastatin (Lipitor), the world's most-prescribed cholesterol-lowering medicine with worldwide sales of $12.7 billion world wide. The Ranbaxy stock is down in the red with a sharp loss of 3.65.
Unitech, Power Grid, Siemens, PNB, BPCL, Tata Power, ABB, Hero Honda, Reliance Petroleum, Tata Communications, HCL Technologies and Idea Cellular are among the major losers in the Nifty index.
No comments:
Post a Comment